authors
- Moore, MJ
- Tang, P
- Renouf, D
- Major, Pierre
- Hedley, D
- Paterson, V
- Wang, L
- Dhesy-Thind, B
- Southwood, B
- Doyle, L
A phase II study of Halichondrin B analog eribulin mesylate (E7389) as second-line therapy for patients with advanced pancreatic cancer
Conferences
- Overview
- Research
- Additional Document Info
- View All
Overview
status
publication date
- May 20, 2009
has subject area
- 1103 Clinical Sciences (FoR)
- 1112 Oncology and Carcinogenesis (FoR)
- Oncology & Carcinogenesis (Science Metrix)
published in
- Journal of Clinical Oncology Journal